S100A12 and interstitial lung disease: S100A12 had been identified as an effective inflammatory biomarker of poor prognosis in the familial Mediterranean fever (67), acute respiratory distress syndrome (ARDS) (68, 69), hemodialysis (70), SSc-ILD (71) and so on.